Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $22.0 million.

  • Century Therapeutics' Total Current Liabilities rose 1113.02% to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year increase of 1113.02%. This contributed to the annual value of $129.8 million for FY2024, which is 62723.3% up from last year.
  • Latest data reveals that Century Therapeutics reported Total Current Liabilities of $22.0 million as of Q3 2025, which was up 1113.02% from $14.9 million recorded in Q2 2025.
  • Century Therapeutics' 5-year Total Current Liabilities high stood at $129.8 million for Q4 2024, and its period low was $14.5 million during Q1 2025.
  • Over the past 4 years, Century Therapeutics' median Total Current Liabilities value was $20.4 million (recorded in 2023), while the average stood at $28.1 million.
  • Within the past 5 years, the most significant YoY rise in Century Therapeutics' Total Current Liabilities was 62723.3% (2024), while the steepest drop was 4197.01% (2024).
  • Quarter analysis of 4 years shows Century Therapeutics' Total Current Liabilities stood at $29.8 million in 2022, then crashed by 40.15% to $17.8 million in 2023, then surged by 627.23% to $129.8 million in 2024, then crashed by 83.03% to $22.0 million in 2025.
  • Its last three reported values are $22.0 million in Q3 2025, $14.9 million for Q2 2025, and $14.5 million during Q1 2025.